Recce Pharmaceuticals Ltd
ASX:RCE.AX
0.345 (AUD) • At close June 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2025 Q2 | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | 2013 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6.946 | 0 | 2.381 | 4.365 | 0 | 3.085 | 0 | 0.997 | 0.64 | 0.05 | 1.072 | 0 | 0.68 | 0.862 | 0.427 | 0.139 | 0 | 0.04 | 0.137 | 0.114 | 0 | 0.049 | 0.049 | 0 | 0 |
| Cost of Revenue
| 8.391 | 0.173 | 0.193 | 0.142 | 0.075 | 0.079 | 0.108 | 0.205 | 0.091 | 0.1 | 0.1 | 0.029 | 0.366 | 0.238 | 0.214 | 0.703 | 0.368 | 0.176 | 0.057 | 0.028 | 0.083 | 0.031 | 0.031 | 0.017 | 0.017 |
| Gross Profit
| -1.444 | -0.173 | 2.188 | 4.223 | -0.075 | 3.006 | -0.108 | 0.792 | 0.549 | -0.05 | 0.971 | -0.029 | 0.313 | 0.623 | 0.212 | -0.564 | -0.368 | -0.136 | 0.08 | 0.086 | -0.083 | 0.018 | 0.018 | -0.017 | -0.017 |
| Gross Profit Ratio
| -0.208 | 0 | 0.919 | 0.967 | 0 | 0.974 | 0 | 0.794 | 0.858 | -1.008 | 0.906 | 0 | 0.461 | 0.723 | 0.498 | -4.049 | 0 | -3.408 | 0.585 | 0.755 | -3,961.667 | 0.372 | 0.372 | -85.7 | -85.7 |
| Reseach & Development Expenses
| 8.299 | 0 | 4.723 | 3.085 | 4.082 | 3.806 | 2.418 | 1.68 | 3.877 | 1.259 | 0.726 | 0.093 | 0.323 | 0.178 | 0.194 | 0.642 | 0.357 | 0.142 | 0 | 0.054 | 0 | 0.004 | 0.004 | 0.004 | 0.004 |
| General & Administrative Expenses
| 1.042 | 1.019 | 1.019 | 0.925 | 0.925 | 0.307 | 0.307 | 0.414 | 0.414 | 0.208 | 0.208 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 3.667 | 1.241 | 8.396 | 1.118 | 8.255 | 0.994 | 4.615 | 0.696 | 10.414 | 0.19 | 2.052 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.709 | 12.27 | 9.414 | 7.929 | 9.18 | 9.041 | 4.922 | 4.241 | 10.828 | 2.946 | 2.261 | 1.682 | 0.868 | 0.855 | 0.731 | 0.674 | 0.719 | 3.884 | 0.396 | 0.322 | 0.087 | 0.114 | 0.114 | 0.101 | 0.101 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 13.008 | 12.27 | 9.414 | 7.929 | 9.18 | 9.041 | 4.922 | 4.241 | 10.828 | 2.946 | 2.261 | 1.682 | 1.342 | 1.276 | 1.244 | 1.144 | 1 | 0.743 | 4.032 | 0.351 | 0.102 | 0.154 | 0.154 | 0.13 | 0.13 |
| Operating Income
| -14.453 | -12.444 | -9.608 | -8.07 | -9.255 | -9.12 | -5.03 | -4.446 | -10.918 | -3.047 | -2.361 | -1.711 | -1.029 | -0.601 | -1.031 | -1.677 | -1.368 | -4.212 | -0.433 | -0.265 | -0.185 | -0.136 | -0.136 | -0.146 | -0.146 |
| Operating Income Ratio
| -2.081 | 0 | -4.034 | -1.849 | 0 | -2.956 | 0 | -4.458 | -17.059 | -60.932 | -2.203 | 0 | -1.513 | -0.697 | -2.415 | -12.041 | 0 | -105.378 | -3.158 | -2.328 | -8,803.238 | -2.802 | -2.802 | -755.364 | -755.364 |
| Total Other Income Expenses Net
| -0.021 | -0.381 | -0.135 | -0.096 | 0.033 | 0.032 | 0.047 | 0.199 | 0.086 | 0.012 | -0.042 | -0.013 | -0.037 | -0.029 | -0.013 | -0.016 | 0.035 | 3.327 | -3.523 | -0 | -0 | -0 | -0 | -0 | -0 |
| Income Before Tax
| -14.473 | -12.825 | -9.743 | -8.166 | -9.223 | -9.088 | -4.984 | -4.247 | -10.832 | -2.985 | -2.404 | -1.724 | -1.065 | -0.63 | -1.044 | -1.693 | -1.333 | -0.884 | -3.956 | -0.265 | -0.185 | -0.136 | -0.136 | -0.146 | -0.146 |
| Income Before Tax Ratio
| -2.084 | 0 | -4.091 | -1.871 | 0 | -2.946 | 0 | -4.259 | -16.924 | -59.699 | -2.243 | 0 | -1.567 | -0.731 | -2.446 | -12.154 | 0 | -22.121 | -28.866 | -2.329 | -8,811.333 | -2.804 | -2.804 | -755.711 | -755.711 |
| Income Tax Expense
| -6.738 | -2.625 | -2.281 | -4.311 | 0 | -3.085 | -0 | -0.926 | -0.64 | -0 | -1.072 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -7.735 | -10.2 | -7.462 | -3.855 | -9.223 | -6.003 | -4.984 | -3.321 | -10.192 | -2.985 | -1.332 | -1.724 | -1.065 | -0.63 | -1.044 | -1.693 | -1.333 | -0.884 | -3.956 | -0.265 | -0.185 | -0.136 | -0.136 | -0.146 | -0.146 |
| Net Income Ratio
| -1.114 | 0 | -3.133 | -0.883 | 0 | -1.946 | 0 | -3.33 | -15.924 | -59.699 | -1.243 | 0 | -1.567 | -0.731 | -2.446 | -12.154 | 0 | -22.121 | -28.866 | -2.329 | -8,811.333 | -2.804 | -2.804 | -755.711 | -755.711 |
| EPS
| -0.034 | -0.05 | -0.042 | -0.021 | -0.052 | -0.034 | -0.037 | -0.019 | -0.076 | -0.022 | -0.011 | -0.017 | -0.012 | -0.007 | -0.013 | -0.022 | -0.018 | -0.012 | -0.096 | -0.006 | -0.009 | 0 | 0 | 0 | 0 |
| EPS Diluted
| -0.034 | -0.05 | -0.042 | -0.021 | -0.052 | -0.034 | -0.037 | -0.019 | -0.076 | -0.022 | -0.011 | -0.017 | -0.012 | -0.007 | -0.013 | -0.022 | -0.018 | -0.012 | -0.096 | -0.006 | -0.009 | 0 | 0 | 0 | 0 |
| EBITDA
| -7.038 | -12.079 | -9.275 | -7.847 | -9.141 | -9.003 | -4.869 | -4.036 | -10.736 | -2.88 | -2.252 | -1.676 | -1.68 | -1.429 | -1.427 | -1.789 | -1.32 | -4.201 | -0.427 | -0.26 | -0.18 | -0.132 | -0.132 | -0.143 | -0.143 |
| EBITDA Ratio
| -1.013 | 0 | -3.895 | -1.798 | 0 | -2.918 | 0 | -4.046 | -16.774 | -57.593 | -2.101 | 0 | -2.471 | -1.658 | -3.342 | -12.84 | 0 | -105.121 | -3.114 | -2.286 | -8,582.81 | -2.716 | -2.716 | -740.442 | -740.442 |